English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Community

+ Community
Carol Ostrow | Oct 22, 2017

Quadruple amputee proves power of rehabilitation at Wake Forest Baptist

+ Community
Marian Johns | Oct 22, 2017

Wake Forest Baptist receives $9.2 million National Cancer Institute grant

+ Regulatory
Marian Johns | Oct 22, 2017

FDA grants fast-track status to Astellas' acute myeloid leukemia drug

+ Community
Kathy Adams | Oct 22, 2017

Amgen, Boston Children's Hospital team up for study on unusual pain response

+ Technology/Innovation
Carol Ostrow | Oct 22, 2017

NIAID, Caltech researchers consider development of universal flu vaccine in report

+ Technology/Innovation
Marian Johns | Oct 21, 2017

Study: Women with gestational diabetes can reduce heart disease risk with healthy lifestyle

+ Community
Marian Johns | Oct 21, 2017

Eli Lilly announces fourth-quarter dividend

+ Regulatory
Kathy Adams | Oct 20, 2017

Hargan declares public health emergency in California

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns

  • « First
  • «
  • …
  • 365
  • 366
  • 367
  • 368
  • 369
  • 370
  • 371
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily